首页> 外国专利> RECOMBINANT SCFV LYM-1 ANTIBODY COMPRISING LYSINE RESIDUES, GENE ENCODING THE SAME, HOST CELL EXPRESSING THE GENE, AND COMPOSITION AND METHOD OF TREATING OR DIAGONISING A CANCER COMPRISING THE ANTIBODY

RECOMBINANT SCFV LYM-1 ANTIBODY COMPRISING LYSINE RESIDUES, GENE ENCODING THE SAME, HOST CELL EXPRESSING THE GENE, AND COMPOSITION AND METHOD OF TREATING OR DIAGONISING A CANCER COMPRISING THE ANTIBODY

机译:包含赖氨酸残基,编码相同基因的基因,宿主细胞表达基因的重组SCFV LYM-1抗体以及治疗或诊断包含抗体的癌症的组成和方法

摘要

A scFv Lym-1 recombinant antibody containing lysine residues is provided to introduce a radioactive ignition chelator by inserting four lysine residues into the scFv Lym-1. A scFv Lym-1 recombinant antibody comprises an amino acid sequence of scFv (single chain variable fragment) Lym-1 antibody, histidine tag(His Tag), and four lysine amino acids from N-terminal C-terminal in order. The recombinant antibody specifically binds to HLA-DR. The recombinant antibody comprises amino acid of the sequence number 1. A gene coding the recombinant antibody comprises polynucleotide of the sequence number 2. A host cell which expresses the gene is prokaryotic cell. A composition for treating and diagnosing cancer comprises the recombinant antibody and pharmaceutically allowable carrier. The cancer is malignant lymphoma.
机译:提供了含有赖氨酸残基的scFv Lym-1重组抗体,以通过将四个赖氨酸残基插入scFv Lym-1中来引入放射性点火螯合剂。 scFv Lym-1重组抗体依次包含scFv(单链可变片段)Lym-1抗体的氨基酸序列,组氨酸标签(His Tag)和从N端C端开始的四个赖氨酸氨基酸。重组抗体特异性结合HLA-DR。重组抗体包含序列号1的氨基酸。编码重组抗体的基因包含序列号2的多核苷酸。表达该基因的宿主细胞是原核细胞。用于治疗和诊断癌症的组合物包含重组抗体和药学上可接受的载体。癌症是恶性淋巴瘤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号